Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Stocks and securities in focus

Security Change (%) 1w 1m ▼ 1y YTD 3y 5y
G1 Therapeutics -6.170% 0.385% 72.264% 87.282% 32.800% -74.943% -
Fate Therapeutics Inc. -8.630% -15.342% 39.362% 23.485% 19.179% -94.088% -76.778%
Evolus Inc 11.500% 16.667% 26.633% 37.705% 39.227% 34.759% -
Puma Biotechnology Inc. 10.940% -0.795% 21.305% 7.901% -10.474% -47.206% -56.797%
Ocular Therapeutix Inc. -3.370% -8.170% 14.529% 81.508% 69.828% -24.989% 61.496%
Ardelyx Inc. 7.540% 7.309% 12.851% 50.407% -3.979% 293.617% 152.790%
Insmed Inc. 1.480% 0.735% 11.382% 244.221% 139.510% 242.500% 340.741%
Alnylam Pharmace. -0.600% 15.164% 8.023% 45.673% 40.734% 66.233% 255.248%
Savara Inc. 0.470% 1.923% 3.922% 31.677% -1.852% 296.262% 86.620%
Celsion Corp. -29.450% 10.577% 1.770% 2.679% 93.277% -91.434% -94.864%
Bovie Medical Corp -3.280% -7.813% -0.840% -75.918% -50.000% -83.724% -81.987%
Coherus Bioscien. -6.020% -21.368% -4.351% -68.676% -59.145% -88.811% -91.917%
Sarepta Therapeutics 0.530% -1.874% -6.969% 38.831% 50.882% 130.969% 1.505%
Twist Bioscience Corp -19.780% -26.375% -10.688% 101.330% 13.955% -60.202% -
MacroGenics Inc. -6.060% -31.294% -12.180% -21.435% -61.067% -83.557% -73.531%
Actinium Pharmaceuticals Inc. -3.920% -22.008% -12.567% -12.093% 25.442% 1.250% -11.184%
Eli Lilly Corp. -4.160% -0.607% -12.678% 77.419% 39.583% 254.497% 628.117%
Sage Therapeutics Inc. -0.460% -7.964% -12.682% -73.792% -55.970% -75.887% -93.987%
Esperion Therapeutis.Inc. -5.600% -15.652% -13.680% 15.411% -34.373% -85.075% -94.593%
Cellectar BioSciences Inc. -3.660% -13.810% -18.468% -7.179% -20.614% -80.000% -
ImmunityBio Inc. -4.090% -17.009% -25.573% 142.034% -9.237% -54.513% 277.445%
Carisma Therapeutics Inc. 1.100% -4.688% -39.039% -81.277% -65.493% -98.567% -95.499%
Applied Therapeutics Inc 23.530% - - - - - -
Revance Therapeutics Inc. -2.560% - - - - - -